SCHEMBL3346722

SCHEMBL3346722

CCn1c(=O)cnn(-c2ccc(C)c(N)c2)c1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 4/20 0.44
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
KDM4E B2RXH2 3/20 0.38
MAPT P10636 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
RAB9A P51151 5/20 0.35
NPC1 O15118 4/20 0.35
ALDH1A1 P00352 5/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.34
HTT P42858 2/20 0.34
LMNA P02545 1/20 0.34
TSHR P16473 1/20 0.34
NPBWR1 P48145 1/20 0.34
CASP3 P42574 1/20 0.33
SENP8 Q96LD8 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
SENP6 Q9GZR1 1/20 0.33
CA12 O43570 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3347963 0.86 P2RX7 (0.38) P2RX7MEN1KMT2AKDM4EMAPT
SCHEMBL3346714 0.82 P2RX7 (0.50) P2RX7KDM4EMAPTRAB9ANPC1
SCHEMBL3342526 0.82 P2RX7 (0.40) P2RX7MEN1KMT2AKDM4EMAPT
SCHEMBL3344616 0.80 P2RX7 (0.53) P2RX7MEN1KMT2AKDM4EMAPT
SCHEMBL3346925 0.76 MAPT (0.42) MEN1KMT2AKDM4EMAPTNPSR1
SCHEMBL1225427 0.74 P2RX7 (0.40) P2RX7MAPTNPSR1RAB9ANPC1
SCHEMBL3348736 0.70 P2RX7 (0.48) P2RX7MEN1KMT2AKDM4EMAPT
SCHEMBL3347955 0.70 RAB9A (0.42) P2RX7KDM4EMAPTRAB9ANPC1
SCHEMBL3343676 0.70 CA12 (0.51) P2RX7MEN1KMT2AKDM4EMAPT
SCHEMBL10465058 0.69 NPC1 (0.40) MEN1KMT2ARAB9ANPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8435990-B2 Dihydropyrimidone amides as P2X7 modulators ROCHE PALO ALTO LLC (US) 2013-05-07 US disclosed
US-20110028502-A1 DIHYDROPYRIMIDONE AMIDES AS P2X7 MODULATORS BROTHERTON-PLEISS CHRISTINE E 2011-02-03 US disclosed
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX6, P2RX3 P2RX7 8/4885MEN1 2632/4885KMT2A 3250/4885
US-20110028502-A1 DIHYDROPYRIMIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX7, P2RX3 P2RX7 2/4885MEN1 2873/4885KMT2A 3668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.